Invention Grant
US08741893B2 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
有权
6,7-二氢 - [1,3,4]噻二唑并[3,2-a] [1,3]二氮杂衍生物和含有与催眠或麻醉剂相同的药物组合物及其制备方法
![6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation](/docs/US/2014-06-03/US08741893B2/abs.jpg.600x600.jpg)
- Patent Title: 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
- Patent Title (中): 6,7-二氢 - [1,3,4]噻二唑并[3,2-a] [1,3]二氮杂衍生物和含有与催眠或麻醉剂相同的药物组合物及其制备方法
-
Application No.: US14042057Application Date: 2012-04-04
-
Publication No.: US08741893B2Publication Date: 2014-06-03
- Inventor: Ghada S. Hassan , Hussein I. El-Subbagh , Mohamed A. Al-Omar , Kamal E. H. El-Taher , Khalid A. Al-Rashood , Abdulrahman M. Al-Obaid , Adel S. El-Azab , Alaa A.-M. Abdelaziz , Fatmah A. Al-Omary , Mohamed M. Hefnawy
- Applicant: Ghada S. Hassan , Hussein I. El-Subbagh , Mohamed A. Al-Omar , Kamal E. H. El-Taher , Khalid A. Al-Rashood , Abdulrahman M. Al-Obaid , Adel S. El-Azab , Alaa A.-M. Abdelaziz , Fatmah A. Al-Omary , Mohamed M. Hefnawy
- Applicant Address: SA Riyadh
- Assignee: King Saud University
- Current Assignee: King Saud University
- Current Assignee Address: SA Riyadh
- Agency: Lucas & Mercanti, LLP
- Priority: EP11161596 20110408
- International Application: PCT/EP2012/001486 WO 20120404
- International Announcement: WO2012/136356 WO 20121011
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D513/04 ; A61K31/551 ; A61K31/381
![6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation](/abs-image/US/2014/06/03/US08741893B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a compound represented by formula 1 or an addition salt thereof, a pharmaceutical composition containing the compound, a method for its preparation as well as the use of the compound as an hypnotic agent or anesthetic agent: wherein each symbol is as defined in the Specification.
Public/Granted literature
Information query
